Viking Therapeutics, Inc. (VKTX)
35.36
+0.04
(+0.11%)
USD |
NASDAQ |
Dec 31, 12:36
Viking Therapeutics Free Cash Flow: -224.58M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 6.436B |
| Pfizer Inc. | 10.38B |
| Amgen, Inc. | 11.54B |
| Altimmune, Inc. | -66.66M |
| Moderna, Inc. | -2.663B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -94.00M |
| Cash from Investing (Quarterly) | 160.02M |
| Cash from Financing (Quarterly) | 0.48M |
| Free Cash Flow Per Share (Quarterly) | -0.8369 |
| Free Cash Flow to Equity (Quarterly) | -93.88M |
| Free Cash Flow to Firm (Quarterly) | -94.00M |
| Free Cash Flow Yield | -5.67% |